TechFlow reports that on August 20, Bybit today listed one US stock perpetual contract for Moderna (MRNAUSDT), supporting up to 25x leverage. Enjoy limited-time fee discounts concurrent with the launch: limit order fees at 0%, and market order fees at 50% off.
Add to Favorites
Share to Social Media





